Coronavirus Update: Will Dexamethasone Breakthrough Make Remdesivir Irrelevant?

Plus AZ's Vaccine May Only Protect For One Year

The RECOVERY trial has produced clear results for the cheap steroid treatment dexamethasone. What does it mean for Gilead's antiviral remdesivir?  

Old Road Campus
The University of Oxford, which is leading the multi-arm RECOVERY trial

More from COVID-19

More from Scrip